Java founder and Director Professor Desmond Fitzgerald is a world renowned expert in cardiovascular pharmacology.
Java has a specialist interest in:
- Coronary thrombosis
- Antithrombotic therapy
As a full service CRO, we have over 12 years’ experience in conducting cardiology trials across the entire drug development spectrum, ranging from initial studies in Phase I through to post-marketing trials in Phase IV.
Consequently we have developed excellent working relationships with the key Cardiologists in Ireland and the UK, a relationship which we consider critical in ensuring a thorough understanding and appreciation of the factors critical to the success of each project. These relationships are also essential to achieve recruitment targets and for studies to be delivered in line with agreed timelines.
Java also has a wealth of experience conducting cardiovascular clinical trials in the following indications:
- Acute Myocardial Infarction
- Acute Coronary Syndrome
- Coagulation Disorders
- Congestive Cardiac Failure
- Stent Angioplasty
These trials have been conducted in many clinical settings including specialist academic units, leading academic teaching hospitals and primary care units.